Effect of angiotensin II on the antitumor activity and cardiotoxicity of doxorubicin
- 9 April 1990
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 50 (1) , 79-85
- https://doi.org/10.1016/0304-3835(90)90182-w
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Increase in Tumor Vascular Area Due to Increased Blood Flow by Angiotensin II in RatsJNCI Journal of the National Cancer Institute, 1985
- AN EXPERIMENTAL RAT MODEL OF LOCAL BONE CANCER INVASION AND ITS RESPONSIVENESS TO ETHANE-1-HYDROXY-1, 1-BIS(PHOSPHONATE)1985
- Reduced Cardiotoxicity of Doxorubicin Delivered on a Weekly ScheduleAnnals of Internal Medicine, 1983
- Influence of vasoactive drugs on the intratumor distribution of blood flow and vascular volume in a transplantable rat fibrosarcomaZeitschrift für Krebsforschung und Klinische Onkologie, 1983
- A Hypothesis Concerning the Effect of Changes in Scheduling upon the Cardiotoxicity of AdriamycinOncology, 1983
- ADRIAMYCIN-INDUCED NEPHROTIC SYNDROME IN RATS - SEQUENCE OF PATHOLOGIC EVENTS1982
- A New Approach to Cancer Chemotherapy: Selective Enhancement of Tumor Blood Flow With Angiotensin II23JNCI Journal of the National Cancer Institute, 1981
- EFFECT OF VITAMIN-E AGAINST ADRIAMYCIN-INDUCED TOXICITY IN RABBITS1980
- FAILURE OF THE ANTIOXIDANT VITAMIN-E TO PROTECT AGAINST ADRIAMYCIN-INDUCED CARDIOTOXICITY IN THE RABBIT1980
- Effects of Angiotensin II and Noradrenaline on Intrarenal Haemodynamies in the Rat*European Journal of Clinical Investigation, 1976